Article
Development and validation of nanobodies specifically targeting the oncogenic Phosphatase…
medRxiv · 2022 · Caroline N. Smith
Key facts
| Title | Development and validation of nanobodies specifically targeting the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) |
|---|---|
| First author | Caroline N. Smith |
| Journal | medRxiv |
| Published | Jan 26, 2022 |
| DOI | 10.1101/2020.10.02.311787 |
| Devices mentioned | BK110039, K103302 |
| Product codes mentioned | KIT, NDS, NJT, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1